Cevimeline Hydrochloride is an intermediate used in the synthesis of trans-Cevimeline Hydrochloride (C283525), which is a reagent in the preparation of spiro-oxathiolane/quinuclidine sulfoxide derivative for the treatment of central nervous and cholinergic system disease or disorders.